Evidence map›Paper›PMID 40746020›Full record

ArticleJournal of the European Academy of Dermatology and Venereology : JEADV2026

Sita- and saxagliptin use and autoantibodies to autoimmune bullous diseases: A cross-sectional study.

Sören Dräger, Claudia Kauderer, Svenja Meyhöfer, Leonie Dräger, Jens U Marquardt, Ralf J Ludwig, Stephan Arndt, Katharina Boch, Katja Bieber

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of the European Academy of Dermatology and Venereology : JEADV, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sören DrägerLübeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany.ORCID https://orcid.org/0000-0002-3701-8365
Claudia KaudererLübeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany.
Svenja MeyhöferDepartment of Internal Medicine I, University Hospital Schleswig-Holstein (UKSH), Lübeck, Germany.
Leonie DrägerDepartment of Internal Medicine I, University Hospital Schleswig-Holstein (UKSH), Lübeck, Germany.
Jens U MarquardtDepartment of Internal Medicine I, University Hospital Schleswig-Holstein (UKSH), Lübeck, Germany.
Ralf J LudwigLübeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany.ORCID https://orcid.org/0000-0002-1394-1737
Stephan ArndtPraxiszentrum Diabendo, Rostock, Germany.
Katharina BochLübeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany.ORCID https://orcid.org/0000-0003-1899-4886
Katja BieberLübeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany.ORCID https://orcid.org/0000-0002-3855-6683

Funding

Cluster of Excellence "Precision Medicine in Chronic Inflammation" EXC 2167Collaborative research center "Pathomechanisms of Antibody-mediated Autoimmunity" CRC 1526Research Training Group "Defining and Targeting Autoimmune Pre-Disease" GRK 2633Schleswig-Holstein Excellence-Chair Program by the State of Schleswig Holstein
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

autoimmune blistering diseasesdipeptidyl‐peptidase 4 (DPP4)‐inhibitorsimmunologypemphigoid

Identifiers

PMID40746020
PMCPMC13014444

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.